Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Horvath

Showing results (211-220 of 279) with videos related to

Pageof 28
Sort By:
Ebiomedicine|August 7, 2023
BRCA-deficient metastatic prostate cancer has an adverse prognosis and distinct genomic phenotypeHeidi Fettke, Chao Dai, Edmond M Kwan, et al.
Cancer Research|July 17, 2001
Frequent loss of estrogen receptor-beta expression in prostate cancerL G Horvath, S M Henshall, C S Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 9, 2013
Patterns of DNA mutations and ALK rearrangement in resected node negative lung adenocarcinomaPo Yee Yip, Bing Yu, Wendy A Cooper, et al.
Neoplasia (New York, N.Y.)|March 23, 2019
Characterization of the ERG-regulated Kinome in Prostate Cancer Identifies TNIK as a Potential Therapeutic TargetRachel S Lee, Luxi Zhang, Adeline Berger, et al.
Journal of Molecular Neuroscience : MN|April 25, 2012
PACAP is an endogenous protective factor-insights from PACAP-deficient miceD Reglodi, P Kiss, K Szabadfi, et al.
Journal of Clinical Pathology|June 13, 2013
EGFR mutant-specific immunohistochemistry has high specificity and sensitivity for detecting targeted activating EGFR mutations in lung adenocarcinomaW A Cooper, B Yu, P Y Yip, et al.
British Journal of Cancer|April 10, 2014
Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancerH-M Lin, L Castillo, K L Mahon, et al.
The Prostate|March 28, 2024
Clinical validation of circulating GDF15/MIC-1 as a marker of response to docetaxel and survival in men with metastatic castration-resistant prostate cancerKate L Mahon, Sarah Im Sutherland, Hui Ming Lin, et al.
American Heart Journal|November 25, 2010
Thrombus aspiration followed by direct stenting: a novel strategy of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction. Results of the Polish-Italian-Hungarian RAndomized ThrombEctomy Trial (PIHRATE Trial)Dariusz Dudek, Waldemar Mielecki, Francesco Burzotta, et al.
Cancers|October 14, 2022
Modulation of Plasma Lipidomic Profiles in Metastatic Castration-Resistant Prostate Cancer by SimvastatinBlossom Mak, Hui-Ming Lin, Thy Duong, et al.
Pageof 28

Showing results (211-220 of 279) with videos related to

Sort By:
Pageof 28
Ebiomedicine|August 7, 2023
BRCA-deficient metastatic prostate cancer has an adverse prognosis and distinct genomic phenotypeHeidi Fettke, Chao Dai, Edmond M Kwan, et al.
Cancer Research|July 17, 2001
Frequent loss of estrogen receptor-beta expression in prostate cancerL G Horvath, S M Henshall, C S Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 9, 2013
Patterns of DNA mutations and ALK rearrangement in resected node negative lung adenocarcinomaPo Yee Yip, Bing Yu, Wendy A Cooper, et al.
Neoplasia (New York, N.Y.)|March 23, 2019
Characterization of the ERG-regulated Kinome in Prostate Cancer Identifies TNIK as a Potential Therapeutic TargetRachel S Lee, Luxi Zhang, Adeline Berger, et al.
Journal of Molecular Neuroscience : MN|April 25, 2012
PACAP is an endogenous protective factor-insights from PACAP-deficient miceD Reglodi, P Kiss, K Szabadfi, et al.
Journal of Clinical Pathology|June 13, 2013
EGFR mutant-specific immunohistochemistry has high specificity and sensitivity for detecting targeted activating EGFR mutations in lung adenocarcinomaW A Cooper, B Yu, P Y Yip, et al.
British Journal of Cancer|April 10, 2014
Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancerH-M Lin, L Castillo, K L Mahon, et al.
The Prostate|March 28, 2024
Clinical validation of circulating GDF15/MIC-1 as a marker of response to docetaxel and survival in men with metastatic castration-resistant prostate cancerKate L Mahon, Sarah Im Sutherland, Hui Ming Lin, et al.
American Heart Journal|November 25, 2010
Thrombus aspiration followed by direct stenting: a novel strategy of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction. Results of the Polish-Italian-Hungarian RAndomized ThrombEctomy Trial (PIHRATE Trial)Dariusz Dudek, Waldemar Mielecki, Francesco Burzotta, et al.
Cancers|October 14, 2022
Modulation of Plasma Lipidomic Profiles in Metastatic Castration-Resistant Prostate Cancer by SimvastatinBlossom Mak, Hui-Ming Lin, Thy Duong, et al.
Pageof 28